Patents Assigned to Affigen, LLC
  • SEQUENCING-DIRECTED SELECTION OF TUMOR THERANOSTICS
    Publication number: 20190292275
    Abstract: The present disclosure relates to therapies for the treatment of tumor, autoimmune diseases, or other diseases. In some embodiments, the present disclosure can relate to subject-specific selection of humanized antibodies targeting clonal lineage specific marker proteins.
    Type: Application
    Filed: January 11, 2019
    Publication date: September 26, 2019
    Applicant: Affigen, LLC
    Inventors: David J. States, Carlos F. Santos
  • Method of making patient specific anti-idiotype antibodies
    Patent number: 10221249
    Abstract: The present disclosure relates to therapies for the treatment of tumor, autoimmune diseases, or other diseases. In some embodiments, the present disclosure can relate to subject-specific selection of humanized antibodies targeting clonal lineage specific marker proteins.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: March 5, 2019
    Assignee: Affigen, LLC
    Inventors: David J. States, Carlos F. Santos